{"id":"https://openalex.org/W2590899452","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.630","title":"Longer-term cardiac safety and outcomes of dose dense (dd) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) and trastuzumab (H) with and without lapatinib (L) in patients (pts) with early breast cancer (BC).","display_name":"Longer-term cardiac safety and outcomes of dose dense (dd) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) and trastuzumab (H) with and without lapatinib (L) in patients (pts) with early breast cancer (BC).","publication_year":2013,"publication_date":"2013-05-20","ids":{"openalex":"https://openalex.org/W2590899452","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.630","mag":"2590899452"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2013.31.15_suppl.630","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.630","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2013.31.15_suppl.630","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067642403","display_name":"Patrick Glyn Morris","orcid":"https://orcid.org/0000-0002-6055-5273","observed_orcids":["https://orcid.org/0000-0002-6055-5273"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patrick Glyn Morris","raw_affiliation_strings":["Memorial Sloan-Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002918170","display_name":"Neil M. Iyengar","orcid":"https://orcid.org/0000-0002-9773-5235","observed_orcids":["https://orcid.org/0000-0002-9773-5235"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Neil M. Iyengar","raw_affiliation_strings":["Memorial Sloan-Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103144947","display_name":"Sujata N Patil","orcid":"https://orcid.org/0000-0002-7347-793X","observed_orcids":["https://orcid.org/0000-0002-7347-793X"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sujata Patil","raw_affiliation_strings":["Memorial Sloan-Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035950254","display_name":"Carol C. L. Chen","orcid":"https://orcid.org/0000-0003-1022-5978","observed_orcids":["https://orcid.org/0000-0003-1022-5978"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carol Chen","raw_affiliation_strings":["Memorial Sloan-Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001265699","display_name":"Alyson Abbruzzi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alyson Abbruzzi","raw_affiliation_strings":["Memorial Sloan-Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072128358","display_name":"Robert James Lehman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert James Lehman","raw_affiliation_strings":["Memorial Sloan-Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056374636","display_name":"Richard M. Steingart","orcid":"https://orcid.org/0000-0002-7650-0242","observed_orcids":["https://orcid.org/0000-0002-7650-0242"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard Steingart","raw_affiliation_strings":["Memorial Sloan-Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078465445","display_name":"Kevin Charles Oeffinger","orcid":"https://orcid.org/0000-0003-0806-7894","observed_orcids":["https://orcid.org/0000-0003-0806-7894"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kevin C. Oeffinger","raw_affiliation_strings":["Memorial Sloan-Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022319770","display_name":"NU Lin","orcid":"https://orcid.org/0000-0003-2263-5413","observed_orcids":["https://orcid.org/0000-0003-2263-5413"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nancy Lin","raw_affiliation_strings":["Dana-Farber Cancer Insitute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Insitute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017550097","display_name":"Beverly Moy","orcid":"https://orcid.org/0000-0003-3472-1140","observed_orcids":["https://orcid.org/0000-0003-3472-1140"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Beverly Moy","raw_affiliation_strings":["Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060188343","display_name":"Steven E. Come","orcid":"https://orcid.org/0000-0001-8136-2908","observed_orcids":["https://orcid.org/0000-0001-8136-2908"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven E. Come","raw_affiliation_strings":["Beth Israel Deaconess Medical Center, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beth Israel Deaconess Medical Center, Boston, MA","institution_ids":["https://openalex.org/I1316535847"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070245248","display_name":"Eric P. Winer","orcid":"https://orcid.org/0000-0002-8819-1723","observed_orcids":["https://orcid.org/0000-0002-8819-1723"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric P. Winer","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039225060","display_name":"Larry Norton","orcid":"https://orcid.org/0000-0003-3701-9250","observed_orcids":["https://orcid.org/0000-0003-3701-9250"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Larry Norton","raw_affiliation_strings":["Memorial Sloan-Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047713528","display_name":"Clifford A. Hudis","orcid":"https://orcid.org/0000-0001-7144-8791","observed_orcids":["https://orcid.org/0000-0001-7144-8791"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Clifford Hudis","raw_affiliation_strings":["Memorial Sloan-Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5068207600","display_name":"Chau T. Dang","orcid":"https://orcid.org/0000-0001-5133-2265","observed_orcids":["https://orcid.org/0000-0001-5133-2265"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chau T. Dang","raw_affiliation_strings":["Memorial Sloan-Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"31","issue":"15_suppl","first_page":"630","last_page":"630"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11535","display_name":"Chemotherapy-induced cardiotoxicity and mitigation","score":0.8823000192642212,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11535","display_name":"Chemotherapy-induced cardiotoxicity and mitigation","score":0.8823000192642212,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.031300000846385956,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.025299999862909317,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.8610000014305115},{"id":"https://openalex.org/keywords/early-breast-cancer","display_name":"early breast cancer","score":0.8610000014305115},{"id":"https://openalex.org/keywords/dose-dense-chemotherapy","display_name":"dose-dense chemotherapy","score":0.8360000252723694},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.753000020980835},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.9959999918937683},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.9760000109672546},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.9909999966621399},{"id":"https://openalex.org/keywords/lapatinib","display_name":"lapatinib","score":0.9929999709129333},{"id":"https://openalex.org/keywords/congestive-heart-failure","display_name":"congestive heart failure","score":0.8479999899864197},{"id":"https://openalex.org/keywords/cardiotoxicity","display_name":"cardiotoxicity","score":0.9110000133514404},{"id":"https://openalex.org/keywords/left-ventricular-ejection-fraction","display_name":"left ventricular ejection fraction","score":0.9459999799728394},{"id":"https://openalex.org/keywords/distant-disease-free-survival","display_name":"distant disease-free survival","score":0.8500000238418579},{"id":"https://openalex.org/keywords/her2-targeted-therapy","display_name":"HER2-targeted therapy","score":0.7089999914169312}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9327863454818726},{"id":"https://openalex.org/C78085059","wikidata":"https://www.wikidata.org/wiki/Q641303","display_name":"Ejection fraction","level":3,"score":0.6938210725784302},{"id":"https://openalex.org/C2777329042","wikidata":"https://www.wikidata.org/wiki/Q420323","display_name":"Lapatinib","level":5,"score":0.6680113673210144},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.6632975935935974},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6343690156936646},{"id":"https://openalex.org/C2778233292","wikidata":"https://www.wikidata.org/wiki/Q2118956","display_name":"Cardiotoxicity","level":3,"score":0.5441398024559021},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.5307507514953613},{"id":"https://openalex.org/C2776802502","wikidata":"https://www.wikidata.org/wiki/Q417589","display_name":"Anthracycline","level":4,"score":0.5040596723556519},{"id":"https://openalex.org/C2778658803","wikidata":"https://www.wikidata.org/wiki/Q1592932","display_name":"Pegfilgrastim","level":5,"score":0.43713611364364624},{"id":"https://openalex.org/C2777511904","wikidata":"https://www.wikidata.org/wiki/Q425227","display_name":"Taxane","level":4,"score":0.4283333420753479},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.39577987790107727},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3948490619659424},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3707551956176758},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3663065731525421},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.35613149404525757},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.33194679021835327},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.26351499557495117},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.18160882592201233},{"id":"https://openalex.org/C2778850193","wikidata":"https://www.wikidata.org/wiki/Q3775974","display_name":"Febrile neutropenia","level":4,"score":0.1203298568725586}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2013.31.15_suppl.630","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.630","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2013.31.15_suppl.630","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4245442882","https://openalex.org/W1566338804","https://openalex.org/W2624925742","https://openalex.org/W1984361364","https://openalex.org/W2528394928","https://openalex.org/W1968337229","https://openalex.org/W2018306900","https://openalex.org/W2130936824","https://openalex.org/W2259233976","https://openalex.org/W2242326692"],"abstract_inverted_index":{"630":[0],"Background:":[1],"The":[2,214],"addition":[3,38,133],"of":[4,25,34,39,61,80,125,134,150,187,225,237,273,293,310],"H":[5,116,145,311],"to":[6,42],"chemotherapy":[7],"has":[8],"improved":[9],"outcomes":[10,322],"in":[11,66],"HER2-positive":[12],"early":[13,85],"BC.":[14],"This":[15,295],"approach":[16],"is":[17,205,287,296],"associated":[18,52,288],"with":[19,53,71,154,283],"(w/)":[20],"an":[21],"increased":[22],"risk":[23,292],"(<4%)":[24],"congestive":[26],"heart":[27],"failure":[28],"(CHF).":[29],"At":[30],"a":[31,77,234,290],"median":[32,185,216,235],"f/u":[33],"36":[35],"months,":[36],"the":[37,59,132,184,194,299,305],"anti-HER2":[40],"Rx":[41],"dose-dense":[43],"(every":[44],"2":[45,67,275],"weeks)":[46],"anthracycline-taxane":[47],"therapy":[48],"(Rx)":[49],"was":[50,146,161,218],"not":[51],"excess":[54],"cardiotoxicity.":[55],"Here":[56],"we":[57],"report":[58],"incidence":[60],"NYHA":[62],"Class":[63],"III/IV":[64],"CHF":[65,262],"phase":[68,307],"II":[69],"studies":[70,276,309],"longer":[72],"follow-up.":[73],"Methods:":[74],"We":[75],"conducted":[76],"retrospective":[78],"review":[79],"pts":[81,100,176,182,228,253],"w/":[82,115,123,183,289,298,312],"HER2":[83],"+":[84],"stage":[86],"BC":[87],"treated":[88],"at":[89,233,267],"MSKCC":[90],"and":[91,131,152,177,203,209,239,248],"DF/HCC":[92],"on":[93],"two":[94],"trials:":[95],"In":[96,142,222],"trial":[97,327],"A":[98,173,202],"-":[99],"received":[101],"dd":[102,279],"AC":[103,151,280],"(60/600":[104],"mg/m2)":[105],"x":[106,111,117,129,139],"4":[107,112,249],"\u2192":[108,281],"T":[109,127],"(175mg/m2)":[110],"(w/":[113],"pegfilgrastim)":[114],"1":[118,140,260],"year.":[119,141],"Trial":[120,172,178],"B":[121,179,204],"differed":[122],"use":[124],"weekly":[126],"(80mg/m2)":[128],"12":[130],"L":[135,286],"(1000mg":[136],"orally":[137],"daily)":[138],"both":[143],"trials,":[144],"begun":[147],"after":[148],"completion":[149],"concurrent":[153],"T.":[155],"Left":[156],"ventricular":[157],"ejection":[158],"fraction":[159],"(LVEF)":[160],"prospectively":[162],"assessed":[163],"by":[164],"multi-gated":[165],"acquisition":[166],"scan":[167],"serially":[168],"throughout":[169],"Rx.":[170],"Results:":[171],"enrolled":[174,180],"70":[175],"95":[181],"age":[186],"46":[188],"years":[189],"(range":[190,220],"27-73":[191],"years).":[192],"Overall,":[193],"5-year":[195],"distant":[196],"disease-free":[197],"survival":[198],"(DDFS)":[199],"for":[200],"trials":[201],"92%":[206],"(95%Cl;":[207],"83-97%)":[208],"89%":[210],"(95%CI;":[211],"81-94%),":[212],"respectively.":[213],"baseline":[215],"LVEF":[217],"68%":[219],"52-81%).":[221],"total,":[223],"28":[224],"165":[226],"(17%)":[227],"had":[229],"pre-existing":[230],"hypertension.":[231],"Now":[232],"follow-up":[236,272],"84":[238],"57":[240],"months":[241],"respectively,":[242],"only":[243],"one":[244],"(1.4%,":[245],"95%CI;":[246,251],"1.36-7.7%)":[247],"(4.2%,":[250],"4.2-10.4%)":[252],"developed":[254],"CHF.":[255,294],"Since":[256],"our":[257],"earlier":[258],"report,":[259],"additional":[261],"event":[263],"occurred":[264],"(Trial":[265],"B)":[266],"month":[268],"44.":[269],"Conclusions:":[270],"Longer":[271],"these":[274],"demonstrate":[277],"that":[278],"TH":[282],"or":[284,318],"without":[285,319],"low":[291],"consistent":[297],"long-term":[300],"cardiac":[301],"toxicity":[302],"reported":[303],"from":[304],"randomized":[306],"III":[308],"conventionally":[313],"scheduled":[314],"anthracycline-based":[315],"regimens":[316],"(with":[317],"taxanes).":[320],"DDFS":[321],"are":[323],"also":[324],"encouraging.":[325],"Clinical":[326],"information:":[328],"NCT00482391.":[329]},"counts_by_year":[{"year":2015,"cited_by_count":1}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2017-03-03T00:00:00"}